Erlonat

✅ Treats Non-Small Cell Lung Cancer
✅ Inhibits Epidermal Growth Factor
✅ Effective Pancreatic Cancer Treatment
✅ Oral Administration Convenience
✅ Slows Cancer Progression

This product is currently out of stock and unavailable.

Erlonatmg Tablet is prescribed for treating non-small cell lung cancer and pancreatic cancer.

This medication should be taken on an empty stomach, either one hour before or two hours after meals. Continue treatment as directed by your physician. The treatment duration depends on your individual response and medical requirements. Strictly follow your doctor’s instructions regarding dosage, as improper use or overdose may lead to serious adverse effects. While benefits may take weeks or months to become apparent, do not discontinue use without medical advice.

Common side effects include nausea, vomiting, fatigue, skin rash, and weight reduction. Severe diarrhea may occur – maintain proper hydration and consult your doctor if persistent. This medication increases sun sensitivity; wear protective clothing and sunscreen when outdoors. Notify your healthcare provider immediately if you experience mouth ulcers, vision changes, or breathing difficulties. Regular liver function tests may be required during treatment.

Inform your medical team about all medications you’re taking due to potential interactions. This drug is contraindicated during pregnancy and breastfeeding. Both male and female patients should use effective contraception during therapy. Smoking cessation is recommended as tobacco may interfere with the medication’s effectiveness. Maintain at least a two-hour interval between this cancer medication and antacids or other drugs.

THERAPEUTIC APPLICATIONS OF ERLONAT TABLET

  • Management of non-small cell lung carcinoma
  • Treatment of pancreatic adenocarcinoma

THERAPEUTIC ADVANTAGES

For Non-small cell lung carcinoma

As a predominant form of lung cancer affecting both smokers and non-smokers, non-small cell lung cancer requires specialized treatment. Erlonatmg Tablet serves as an effective therapeutic option, administered either as monotherapy or in combination regimens. This potent medication carries significant toxicity risks – thorough discussion of risk-benefit analysis with your oncologist is essential. Patients should abstain from alcohol consumption during treatment and maintain adequate hydration.

ADVERSE EFFECTS OF ERLONAT TABLET

Most adverse reactions are transient and resolve as your system adapts to the medication. Persistent symptoms or concerns warrant medical consultation.

Frequently observed reactions

  • Abdominal discomfort
  • Ostealgia
  • Dyspnea
  • Irregular bowel movements
  • Respiratory irritation
  • Loose stools
  • Generalized weakness
  • Pyrexia
  • Increased infection susceptibility
  • Myalgia
  • Emesis
  • Cutaneous eruptions
  • Oral mucositis
  • Regurgitation
  • Decreased body mass

ADMINISTRATION GUIDELINES

Ingest this medication whole with water, without chewing or crushing, exactly as prescribed. Maintain fasting conditions as directed – either one hour before or two hours after meals.

MECHANISM OF ACTION

Erlonatmg Tablet functions as an antineoplastic agent by targeting epidermal growth factor receptors (EGFR) expressed on malignant cells. The medication binds to EGFR tyrosine kinase, thereby inhibiting downstream signaling pathways that promote cellular proliferation and survival in cancerous tissues.

Important Notice:

This information is provided for educational purposes only after thorough medical review. The content does not replace professional medical advice, diagnosis, or treatment. Not all potential interactions, contraindications, or adverse effects may be listed. Always consult your healthcare provider regarding any medical condition or treatment options. Our objective is to facilitate informed discussions between patients and their physicians, not to substitute the doctor-patient relationship.

Strength

100 mg, 150 mg

Quantity

30 Tablet/s, 60 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Natco Pharma

Treatment

Non-small cell lung cancer, Pancreatic cancer

Generic Brand

Estramustine

Reviews

There are no reviews yet

Add a review
Erlonat Erlonat
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot